The relationship between helicobacter pylori infection and gastric cancer

Immediately after Helicobacter pylori (H. pylori) was discovered in 1983, its relationship with upper gastrointestinal diseases has begun to be investigated. This study was carried out to investigate the relationship between H. pylori and gastric cancer by comparing the frequency of H. pylori infection between gastric cancer patients and controls. Histological results were evaluated in the diagnosis of H. pylori. This study included 60 patients who were diagnosed as gastric cancer at the Endoscopy Unit of Education and Research Hospital and were operated at the General Surgery Department of Istanbul Education and Research Hospital. The patients were questioned about major complaints and duration of these complaints, cigarette smoking and tea drinking habits, family history, and previous gastrointestinal surgery. The localization, macroscopic appearance, histology, and extent of the tumor were determined. Endoscopy, biopsy and tomography examinations were used for the localization, shape and spread of the tumor in other patients. In 40 patients undergoing resection, histological presence of H. pylori in tumor-adjacent tissue was detected in 28 (70%) patients. When all patients (60 patients) were evaluated together, H. pylori infection was detected in 40 (66.7%) patients. 40 patients undergoing resection were included in the evaluation. Although the frequency of H. pylori infection was higher in diffuse-type than in intestinal-type, this was not statistically significant. Both patients with intestinal and diffuse gastric cancers were accompanied by H.pylori infection. The rate of H.pylori infection was higher in patients with diffuse gastric cancer. Although H. pylori is one of the etiologic factors for gastric cancer, there was no significant difference in H. pylori infection between those with and without gastric cancer.

PDF

___

Parsonnet J. Helicobacter pylorh. lnfect Dis Clin North Am. 1998;12:185-97.

Testino G, Cornaggia M,Valentini M. Helicobacter pylori pre-neoplastic changes gastric cancer. A point of view. Eur J Gastroenterol Hepatol. 1999;11;357-9.

Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carsinogenesis. Gastroenterol Clin North Am. 2002;31:517-35.

Figueiredo C. Van Doorn LJ, Nogueria C. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001;36:128-35.

Siman JH, Forsgren A, Berglund G, et al. Association between Helicobacter pylori and gastric carcinoma in city of Malmö, Sweden. a prospective study. Scand J Gastroenterol. 1997;32:1215-21.

Fuchs CS, Mayer RJ. Gastric carcinoma. N Eng J Med. 1995;333:32-41.

Parsonnet J, Vandersteen D, Goates J, et al. Helicobacter pylori in intestinal and diffuse type gastric adenocarcinoma. J Natl Cancer Inst. 1991;83:640-3.

Hanson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicatör of gastric adenocarcinoma. Gastroenterology. 1993;105:1098-103.

Nogueria AM, Ribeiro GM, Rodrigues MA. t al. Prevalance of H.pylori in Brazilian patients with gastric carcinoma. Am J Clin Pathol. 1993;100:263-9.

Correa P, Fox C, Fontham E, et al. Helicobacter pylori and gastric carcinoma: Serum antibody prevalance in populations with contrasting cancer risks. Cancer. 1990;66:2569-74.

Forman D. The Eurogast Study Group. An International association and gastric cancer. Lancet. 1993;341:1359-62.

Forman D, Newel DG, Fullerton F, et al. Association between infection with H.Pylori and risk of gastnc cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-5.

Parsonnett J, Friedman GD, Vandessteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-31.

Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterol. 1992;102:760-6.

Blaser MJ. Helicobacter pylori and gastric diseases, science, medicine and future. BMJ. 1998;316:1507-10

Akbayir N. Cevit R, Egilmez R. Gastrik Kanserlerde Helicobacter pylori histolojik tip, lokalizasyon ve metaplazi arasındaki ilişkiler. Endoskopi. 2002;13:49-54.

Loffeld RJ, Williem l, Flending JA, et al. Helicobacter Pylori and gastnc carcinoma. Histopathology 1990;17:537-41.

Tsujimoto Y. Finger LR, Yunis J. et al, Cloning of the chromosome breakpoint of neoptastic B cells with the t (14;18) chromosome translocation. Science.1984;226:1097-9.

Rudi J, Müller M. von Herbay A, et al. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol. 1995;30:958-63.

Blaser MJ, Kobayashi K, Clover TL, et al. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer. 1993;55:799-80.

Lin JT, Wang JT, Wang TH, et al. Helicobacter pylori infection in a rodomly selected population, healty volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand J Gastroenterol. 1993;28:1067-72.

Forman D, Sitas F, Newell DG, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural china. Int J Cancer. 1990;46:608-11.

Ozden A, Dumlu S, Donderci O, et al, H.Pilori infeksiyonunun ülkemizde seroepidemiyolojisi. Gastroenteroloji. 1992;3:664-8.